Biomedical Engineering Reference
In-Depth Information
104. Fang B, Shi M, Liao L et al (2004) Systemic infusion of FLK1(_) mesenchymal stem cells
ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 78:83-88
105. Zhao DC, Lei JX, Chen R et al (2005) Bone marrow derived mesenchymal stem cells
protect against experimental liver fibrosis in rats. World J Gastroenterol 11:3431-3440
106. Oyagi S, Hirose M, Kojima M et al (2006) Therapeutic effect of transplanting HGF-treated
bone marrow mesenchymal cells into CCl4- injured rats. J Hepatol 44:742-748
107. Houlihan DD, Newsome PN (2008) Critical review of clinical trials of bone marrow stem
cells in liver disease. Gastroenterology 135:438-450
108. Gaia S, Smedile A, Omede P et al (2006) Feasibility and safety of G-CSF administration to
induce bone marrow-derived cells mobilization in patients with end stage liver disease.
J Hepatol 45:13-19
109. Terai S, Ishikawa T, Omori K et al (2006) Improved liver function in patients with liver
cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 24:2292-2298
110. Mohamadnejad M, Namiri M, Bagheri M et al (2007) Phase 1 human trial of autologous
bone marrow-hematopoietic stem cell transplantation in patients with decompensated
cirrhosis. World J Gastroenterol 28:3359-3363
111. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M et al (2007) Phase 1 trial of
autologous
bone
marrow
mesenchymal
stem
cell
transplantation
in
patients
with
decompensated liver cirrhosis. Arch Iran Med 10:459-466
112. Lyra AC, Soares MB, da Silva LF et al (2007) Feasibility and safety of autologous bone
marrow mononuclear cell transplantation in patients with advanced chronic liver disease.
World J Gastroenterol 13:1067-1073
113. Lyra AC, Soares MB, da Silva LF et al (2007) A pilot randomised controlled study used to
evaluate efficacy of autologous bone marrow mononuclear cells transplantation in patients
with advanced chronic liver disease (abstr). Hepatology 46(Suppl 1):271A
114. Gordon MY, Levicar N, Pai M et al (2006) Characterisation and clinical application of
human CD34_ stem/progenitor cell populations mobilized into the blood by granulocyte
colony-stimulating factor. Stem Cells 24:1822-1830
115. Levicar N, Pai M, Habib NA et al (2008) Long-term clinical results of autologous infusion
of mobilized adult bone marrow derived CD34_ cells in patients with chronic liver disease.
Cell Prolif 41:115-125
116. Yannaki E, Anagnostopoulos A, Kapetanos D et al (2006) Lasting amelioration in the
clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized
peripheral blood stem cells. Exp Hematol 34:1583-1587
117. am Esch JS 2
nd
, Knoefel WT, Klein M et al. (2005) Portal application of autologous
CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration.
Stem Cells 23:463-470
118. Pai M, Zacharoulis D, Milicevic MN, Helmy S, Jiao LR et al (2008) Autologous infusion of
expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic
liver cirrhosis. Am J Gastroenterol 103:1952-1958
119. Di Campli MA, Zocco N, Saulnier A, Grieco G, Rapaccini G, Addolorato C, Rumi A,
Santoliquido G, Leone G, Gasbarrini A, Gasbarrini C (2007) Safety and efficacy profile of
G-CSF therapy in patients with acute on chronic liver failure. Dig Liver Dis 39:1071-1076
120. Garg V, Garg H, Khan A, Trehanpati N, Kumar A, Sharma BC, Sakhuja P, Sarin SK (2011)
Granulocyte-colony stimulating factor mobilizes CD34+ cells and improves survival of
patients with acute-on-chronic liver failure. Gastroenterology 142(3):505-551
121. Nussler A, Konig S, Ott M et al (2006) Present status and perspectives of cell-based
therapies for liver diseases. J Hepatol 45:144-159
122. Fisher
RA,
Strom
SC
(2006)
Human
hepatocyte
transplantation:
worldwide
results.
Transplantation 82:441-449
123. Fitzpatrick E, Mitry RR, Dhawan A (2009) Human hepatocyte transplantation: state of the
art. J Intern Med 266(4):339-357
124. Fox IJ, Chowdhury JR, Kaufman SS et al (1998) Treatment of the Crigler-Najjar syndrome
type I with hepatocyte transplantation. N Engl J Med 338:1422-1426
